Journals / Gülhane Tıp Dergisi / 2008 / Cilt: 50 - Sayı: 1

How much innocent are recurrent maternal CMV infections? a case report of a newborn with cytomegalic inclusion disease

Rekürren maternal CMV enfeksiyonları ne kadar masum? sitomegalik inklüzyon hastalığı olan bir yenidoğanın sunumu

Pages
34–38
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additionally we aimed to point out the necessity of making screening tests in a manner to iden- tify maternal primary as well as recurent infections in coun- tries like ours in where seroprevalence of CMV approaches to 100% in early ages.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:How much innocent are recurrent maternal CMV infec- tions?
📊
Key Findings & Data:However, it has been reported that there are no significant differences in the inci- dence of cytomegalic inclusion disease, clinical presentation of the disease and rate of long-term sequela occuring after primary or recurrent maternal infection.
💡
Conclusion & Impact:Additionally we aimed to point out the necessity of making screening tests in a manner to iden- tify maternal primary as well as recurent infections in coun- tries like ours in where seroprevalence of CMV approaches to 100% in early ages.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Sitomegalovirüs enfeksiyonları · Obstetrik doğum · prematür

Abstract

How much innocent are recurrent maternal CMV infec- tions? A case report of a newborn with cytomegalic inclu- sion disease It is known that cytomegalic inclusion disease due to con- genital CMV infection almost always occurs after a primary infection of the mother during her pregnancy who has not preconceptual immunity, and screening tests mainly aim to identify these primary infections. However, it has been reported that there are no significant differences in the inci- dence of cytomegalic inclusion disease, clinical presentation of the disease and rate of long-term sequela occuring after primary or recurrent maternal infection. By presenting cytomegalic inclusion disease which developed in the new- born of a mother with preconceptual immunity in this arti- cle, we aimed to emphasize that recurrent maternal CMV infection may result in serious problems on the contrary to the common knowledge. Additionally we aimed to point out the necessity of making screening tests in a manner to iden- tify maternal primary as well as recurent infections in coun- tries like ours in where seroprevalence of CMV approaches to 100% in early ages.

Özet

Konjenital CMV enfeksiyonuna bağlı sitomegalik inklüzyon hastalığının hemen her zaman, gebelik öncesinde CMV immünitesi olmayan bir annenin gebeliği sırasında geçirdiği primer bir enfeksiyon sonucu oluştuğu bilinmektedir ve tarama testleri de daha çok bu primer enfeksiyonu saptamayı amaçlamaktadır. Bununla birlikte, primer veya rekürren maternal enfeksiyon sonucu sitomegalik inklüzyon hastalığı oluşması insidansında, hastalığın ortaya çıkış kliniğinde ve uzun süredeki sekel oranında anlamlı bir fark olmadığı da bildirilmektedir. Bu yazıda, gebeliği öncesinde CMV immünitesi olan bir annenin yenidoğanında ortaya çıkan sitomegalik inklüzyon hastalığını sunarak, rekürren maternal CMV enfeksiyonunun bilinenin aksine önemli sonuçlar doğurabileceğini vurgulamayı amaçladık. Ayrıca ülkemiz gibi CMV seroprevalansının erken yaşlarda %100'e ulaştığı ülkelerde, tarama testlerinin primer kadar rekürren maternal CMV enfeksiyonlarını da saptamayı amaçlayacak şekilde yapılmasının gerektiğine dikkat çekmek istedik.

🔖

Cite This Article

EKER, İ., SARICI, S. Ü., KUL, M., BALAMTEKİN, N., TUNÇ, T., ÖZCAN, O. (2008). How much innocent are recurrent maternal CMV infections? a case report of a newborn with cytomegalic inclusion disease. Gülhane Tıp Dergisi, Cilt: 50 - Sayı: 1, 34–38. https://ajindex.com/articles/225516

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Spector SA. Bacterial and viral infections. In: Rudolph AM, Hoffman JIE, Rudolph CD (eds). Rudolph's Pediatrics. 20th ed. Stanford: Appleton&Lange, 1996: 629-633
  2. Griffiths PD, Walter S. Cytomegalovirus. Curr Opin Infect Dis 2005; 18: 241-245
  3. Senok AC, Giacometti L, Giuseppe AB. Human cytomegalovirus infections in pregnancy and the new- born: epidemiology, laboratory diagnosis and medico- legal aspects. J Kuwait Med Assoc 2006; 38: 85-93
  4. Skaletskaya A, Bartle LM, Chittenden T, McCormick AL, Mocarski ES, Goldmacher VS. A cytomegalovirus-encod- ed inhibitor of apoptosis that suppresses caspase-8 activa- tion. Proc Natl Acad Sci USA 2001; 98: 7829-7834
  5. Arnoult D, Bartle LM, Skaletskaya A, et al. Cytomegalovirus cell death suppressor vMIA blocks baxbut not bak-mediated apoptosis by binding and sequestering bax at mitochondria. Proc Natl Acad Sci USA 2004; 101: 7988-7993
  6. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002; 15: 680- 715
  7. Ornoy A, Diav-Citrin O. Fetal effects of primary and sec- ondary cytomegalovirus infection in pregnancy. Reprod Toxicol 2006; 21: 399-409
  8. Hizel S, Parker S, Onde U. Seroprevalence of cyto- megalovirus infection among children and females in Ankara, Turkey, 1995. Pediatr Int 1999; 41: 506-509
  9. Schleiss MR. Cytomegalovirus infection. eMedicine Specialties, Pediatrics, Infectious Diseases. February 18, 2005
  10. Munro SC, Hall B, Whybin LR, et al. Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol 2005; 43: 4713-4718
  11. Rutter D, Griffiths P, Trompeter RS. Cytomegalic inclu- sion disease after recurrent maternal infection. Lancet 1985; 23: 1182
  12. Morris DJ, Sims D, Chiswick M, Das VK, Newton VE. Symptomatic congenital cytomegalovirus infection after maternal recurrent infection. Pediatr Infect Dis J 1994; 13: 61-64
  13. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001; 344: 1366-1371
  14. Ahlfors K, Ivarsson SA, Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infec- tion in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis 1999; 31: 443-457
  15. Gaytant MA, Steegers EAP, Semmekrot BA, et al. Congenital cytomegalovirus infection: review of the epi- demiology and outcome. Obstet G